CUREosity - TechVision Fonds


What do you do when family members are affected by diseases such as multiple sclerosis, Down syndrome or paraplegia and you are not statisfied with the therapy options for your family patients, neither in quality nor in quantity? You found a company that solves this problem. That’s what Thomas Saur, Stefan Arand and Marco Faulhammer did in 2018.

The idea: transfer highly targeted therapeutic knowledge tailored to patients into VR glasses. This way, patients with neurological, neurodegenerative or musculoskeletal diseases receive a completely new, constantly available and highly motivating access to effective therapy.

The solution and the management team, which has been further strengthened with Caesar van Heyningen, convinced us so quickly and comprehensively in 2021 that we were eager to work together.

And that is what we are doing now. With over 30 highly motivated CUREosity experts from the fields of physiotherapy, medicine, software and game development as well as sales and marketing. The team is already bringing CUREO from Düsseldorf to many clinics and rehab facilities in the DACH region. The feedback is almost overwhelming and gives us courage!

And we bring a lot from our long established MedTech network to accelerate the journey to the European VR therapy market leader. Reimbursement, regulatory affairs, internationalization: we do what we can. Matter of the heart.

// no layouts found